BIO-RAD laboratories:1110109 [15-022739]
Ended Awarded
- Contract number
- HHSN26100020
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,400
Award facts
- Contract value 100% obligated
- $22,400.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Bio-Rad Laboratories, Inc. was awarded a Blanket Purchase Agreement (BPA) call valued at $22.4K by the National Cancer Institute on March 17, 2015, with a completion date of June 30, 2015. This firm fixed-price contract was issued without a small business set-aside designation and represents a call order against Bio-Rad's larger BPA vehicle with the National Institutes of Health. The work is to be performed at the NIH campus in Bethesda, Maryland. Bio-Rad, a global leader in life science research and clinical diagnostics headquartered in Hercules, California, specializes in advanced scientific instrumentation and laboratory supplies, including polymerase chain reaction systems, droplet digital PCR instruments, thermal cyclers, and associated reagents and consumables critical to cancer research programs.
This award reflects Bio-Rad's established position as a primary federal supplier of sophisticated laboratory technologies to the National Cancer Institute and broader NIH research community. The company holds a significant $10M BPA with the NIH Office of Logistics and Acquisition Operations, valid through December 31, 2025, which facilitates efficient procurement of specialized equipment and consumables to support ongoing research initiatives. Bio-Rad's federal contracting history demonstrates consistent engagement with health agencies including the Centers for Disease Control and Prevention, FDA, and Department of Veterans Affairs, positioning the company as a critical vendor for advanced diagnostic and research capabilities across the federal government.
Quick answers
Who was awarded contract HHSN26100020?
HHSN26100020 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on March 17, 2015.
How much is contract HHSN26100020 worth?
The government has obligated $22,400 on HHSN26100020.
Is contract HHSN26100020 an order under another contract?
Yes. HHSN26100020 is a BPA call under HHSN263199800049653B, a blanket purchase agreement.
Was contract HHSN26100020 competed?
The extent of competition for HHSN26100020 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award